2018 FDA Tides Harvest

2018 FDA Tides Harvest

In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and econ...

Full description

Bibliographic Details
Main Authors: Danah Al Shaer, Othman Al Musaimi, Fernando Albericio, Beatriz G. de la Torre
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Pharmaceuticals
Subjects:
dotatate
drugs
inotersen
Lutathera
oligonucleotides
Onpattro
patisiran
peptides
pharmaceutical market
Tegsedi
Online Access:https://www.mdpi.com/1424-8247/12/2/52
Description
Summary:In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and economics.
ISSN:1424-8247

Similar Items